קביעת מורפולוגיה מיטוכונדריאלית בתאים חיים באמצעות מיקרוסקופיה קונפוקלית

Overview

This study presents a detailed protocol for assessing mitochondrial morphology in live SH-SY5Y cells, relevant for pharmacological studies, especially in Parkinson's disease. The method emphasizes accessibility and lower costs through the use of fluorescence imaging with MitoTracker staining, avoiding complex techniques like electron microscopy.

Key Study Components

Area of Science

• Neuropharmacology
• Mitochondrial function
• Cell imaging techniques

Background

• Challenges in lab cell analysis persist despite manufacturer guidance.
• This study addresses these by outlining a step-by-step protocol for mitochondrial morphology assessment.
• The focus is on reducing costs and enhancing accessibility for researchers.

Purpose of Study

• To develop a reproducible method for analyzing mitochondrial morphology in live cells.
• To facilitate understanding of drug compound relationships with mitochondrial function in neurodegenerative conditions.
• To compare the effectiveness of simple staining methods against more complex imaging techniques.

Methods Used

• The primary platform used is live cell culture.
• SH-SY5Y neuroblastoma cells are employed as the biological model for examining mitochondrial response to pharmacological agents.
• Image acquisition involves fluorescence microscopy and open-source software for data analysis.
• Key steps include cell detachment, MitoTracker staining, and image processing techniques such as skeletonization.

Main Results

• The developed protocol allows for improved visualization and analysis of mitochondrial morphology.
• MPP+ treatment was shown to significantly disrupt mitochondrial structure in treated cells compared to controls.
• Fluorescence intensity and background noise are key factors in imaging quality.

Conclusions

• This study establishes a reliable and cost-effective approach for imaging mitochondrial morphology in live neurons.
• The method enhances understanding of mitochondrial dynamics in drug response, particularly in neurodegenerative disease models.

Frequently Asked Questions